In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Warnex, Inc.

http://www.warnex.ca/

Latest From Warnex, Inc.

Women's Health: Promising Advances, But Challenges Persist

The field of women's health is one of the most progressive medical technology sectors in the US, driven by the aging population, diagnostic advances in deadly ovarian and colorectal cancer, and medical device innovations in gynecologic and urogynecologic disease management, including a shift toward minimally invasive surgery (MIS) techniques and robotics and the addition of a new field: bariatric gynecology. At the WH 2.0 Consensus Conference on Women's Health, held recently in Los Angeles, experts agreed that advances in medical technology are promising better detection and treatment of a host of diseases impacting both premenopausal and postmenopausal women. However, challenges remain in managing obesity-related disease and improving screening for often-undetected cancers in women.

Medical Device

Deals Shaping The Medical Industry (11/2011)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.

BioPharmaceutical Medical Device

Deals Update

A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.

Market & Industry Briefs

Brief summaries of recent medtech market and industry developments. This month we cover CE mark approval for Abbott's Absorb bioresorbable stent, rumors about a takeover of Smith & Nephew, and J&J's cancer detection partnership with Veridex.

Medical Device
See All

Company Information

  • Industry
  • Laboratory Testing Services
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
    • Hematology, Coagulation
    • Molecular Diagnostics & Genetic Testing
    • Therapeutic Drug Monitoring
  • Biotechnology
    • Pharmacogenetics-Pharmacogenomics
UsernamePublicRestriction

Register